Correlation Between Leap Therapeutics and Kodiak Sciences
Can any of the company-specific risk be diversified away by investing in both Leap Therapeutics and Kodiak Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Leap Therapeutics and Kodiak Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Leap Therapeutics and Kodiak Sciences, you can compare the effects of market volatilities on Leap Therapeutics and Kodiak Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Leap Therapeutics with a short position of Kodiak Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Leap Therapeutics and Kodiak Sciences.
Diversification Opportunities for Leap Therapeutics and Kodiak Sciences
0.21 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Leap and Kodiak is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Leap Therapeutics and Kodiak Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kodiak Sciences and Leap Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Leap Therapeutics are associated (or correlated) with Kodiak Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kodiak Sciences has no effect on the direction of Leap Therapeutics i.e., Leap Therapeutics and Kodiak Sciences go up and down completely randomly.
Pair Corralation between Leap Therapeutics and Kodiak Sciences
Given the investment horizon of 90 days Leap Therapeutics is expected to under-perform the Kodiak Sciences. But the stock apears to be less risky and, when comparing its historical volatility, Leap Therapeutics is 1.04 times less risky than Kodiak Sciences. The stock trades about 0.0 of its potential returns per unit of risk. The Kodiak Sciences is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 875.00 in Kodiak Sciences on August 31, 2024 and sell it today you would lose (208.00) from holding Kodiak Sciences or give up 23.77% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Leap Therapeutics vs. Kodiak Sciences
Performance |
Timeline |
Leap Therapeutics |
Kodiak Sciences |
Leap Therapeutics and Kodiak Sciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Leap Therapeutics and Kodiak Sciences
The main advantage of trading using opposite Leap Therapeutics and Kodiak Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Leap Therapeutics position performs unexpectedly, Kodiak Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kodiak Sciences will offset losses from the drop in Kodiak Sciences' long position.Leap Therapeutics vs. X4 Pharmaceuticals | Leap Therapeutics vs. Terns Pharmaceuticals | Leap Therapeutics vs. Day One Biopharmaceuticals | Leap Therapeutics vs. PDS Biotechnology Corp |
Kodiak Sciences vs. Cue Biopharma | Kodiak Sciences vs. Eliem Therapeutics | Kodiak Sciences vs. Inhibrx | Kodiak Sciences vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |